Showing results (131-140 of 219) with videos related to

Sort By:
Pageof 22
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effect of verapamil on the pharmacokinetics of adriamycinD J Kerr, J Graham, J Cummings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
A pilot study of combination therapy with interferon-alpha-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumoursM J Hughes, D J Kerr, J Cassidy, et al.
British Journal of Cancer|February 1, 1991
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumourJ A Goldberg, T Murray, D J Kerr, et al.
EXS|January 1, 1992
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugsD J Kerr, J A Goldberg, J R Anderson, et al.
British Journal of Cancer|November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancerD J Kerr, G J Rustin, S B Kaye, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (iproplatinum, CHIP) in patients with normal and impaired renal function and following intraperitoneal administrationD J Kerr, M Harding, J G Farmer, et al.
The Journal of Endocrinology|January 1, 1983
Accumulation of thiourylene antithyroid drugs in mouse salivary glandJ M Connell, D C McCruden, M Small, et al.
British Journal of Cancer|October 1, 1994
A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastasesH W Warren, J H Anderson, P O'Gorman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Relationship between the pharmacokinetics and toxicity of mitozolomideD J Kerr, J A Slack, P Secrett, et al.
British Medical Journal|May 12, 1973
Remission of thyrotoxicosis during treatment with propranololD G McLarty, B E Brownlie, W D Alexander, et al.
Pageof 22